Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
Clinical trial NCT01927861 · COMPLETED
Trial details
- NCT number
- NCT01927861
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-19
- Primary completion
- 2018-07-12
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.